These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 23455501

  • 1. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.
    Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE.
    J Immunol; 2013 Apr 01; 190(7):3732-9. PubMed ID: 23455501
    [Abstract] [Full Text] [Related]

  • 2. Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.
    Bates JT, Keefer CJ, Slaughter JC, Kulp DW, Schief WR, Crowe JE.
    Virology; 2014 Apr 01; 454-455():139-44. PubMed ID: 24725940
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virus.
    Liu C, Day ND, Branigan PJ, Gutshall LL, Sarisky RT, Del Vecchio AM.
    Virol J; 2007 Jul 10; 4():71. PubMed ID: 17623075
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of neutralizing affinity-matured human respiratory syncytial virus F binding antibodies in the sub-picomolar affinity range.
    Canziani GA, Melero JA, Lacy ER.
    J Mol Recognit; 2012 Mar 10; 25(3):136-46. PubMed ID: 22407977
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
    Djagbare MD, Yu L, Parupudi A, Sun J, Coughlin ML, Rush BS, Sanyal G.
    Vaccine; 2018 Mar 14; 36(12):1673-1680. PubMed ID: 29456016
    [Abstract] [Full Text] [Related]

  • 10. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta.
    Jackson JR, Sathe G, Rosenberg M, Sweet R.
    J Immunol; 1995 Apr 01; 154(7):3310-9. PubMed ID: 7897213
    [Abstract] [Full Text] [Related]

  • 11. Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein.
    Harshbarger W, Abeyrathne PD, Tian S, Huang Y, Chandramouli S, Bottomley MJ, Malito E.
    MAbs; 2021 Apr 01; 13(1):1955812. PubMed ID: 34420474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity.
    Barbas CF, Crowe JE, Cababa D, Jones TM, Zebedee SL, Murphy BR, Chanock RM, Burton DR.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10164-8. PubMed ID: 1279672
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein.
    Mousa JJ, Kose N, Matta P, Gilchuk P, Crowe JE.
    Nat Microbiol; 2017 Jan 30; 2():16271. PubMed ID: 28134924
    [Abstract] [Full Text] [Related]

  • 16. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
    Tsuji I, Vang F, Dominguez D, Karwal L, Sanjali A, Livengood JA, Davidson E, Fouch ME, Doranz BJ, Das SC, Dean HJ.
    J Virol; 2022 Jun 08; 96(11):e0007122. PubMed ID: 35575481
    [Abstract] [Full Text] [Related]

  • 17. Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F.
    McLellan JS, Chen M, Chang JS, Yang Y, Kim A, Graham BS, Kwong PD.
    J Virol; 2010 Dec 08; 84(23):12236-44. PubMed ID: 20881049
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional maturation of the human antibody response to rotavirus.
    Kallewaard NL, McKinney BA, Gu Y, Chen A, Prasad BV, Crowe JE.
    J Immunol; 2008 Mar 15; 180(6):3980-9. PubMed ID: 18322207
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.
    Crowe JE, Firestone CY, Crim R, Beeler JA, Coelingh KL, Barbas CF, Burton DR, Chanock RM, Murphy BR.
    Virology; 1998 Dec 20; 252(2):373-5. PubMed ID: 9878616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.